Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer.
暂无分享,去创建一个
[1] Leaf Huang,et al. BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma , 2018, Cancer Immunology, Immunotherapy.
[2] Yuhua Wang,et al. mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] P. Authié,et al. Targeting interferon-alpha to dendritic cells enhances a CD8+ T cell response to a human CD40-targeted cancer vaccine. , 2017, Vaccine.
[4] Xueling Wu,et al. RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA , 2017, PloS one.
[5] C. Caux,et al. Pattern recognition receptors: immune targets to enhance cancer immunotherapy , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] Jinhong Jiang,et al. Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer , 2017, The Journal of clinical investigation.
[7] Souptik Barua,et al. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer , 2017, Nature Communications.
[8] T. Kawai,et al. Cytosolic nucleic acid sensors and innate immune regulation , 2017, International reviews of immunology.
[9] A. Levitzki,et al. PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses , 2017, Oncotarget.
[10] William Y. Kim,et al. Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors. , 2017, Cancer research.
[11] N. Tinari,et al. Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally , 2017, The Journal of Immunology.
[12] Leaf Huang,et al. Local and transient gene expression primes the liver to resist cancer metastasis , 2016, Science Translational Medicine.
[13] Leaf Huang,et al. Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform , 2016, Theranostics.
[14] K. Ishiwata,et al. Potential applications for sigma receptor ligands in cancer diagnosis and therapy. , 2015, Biochimica et biophysica acta.
[15] X. Ren,et al. Regulatory B cell: New member of immunosuppressive cell club. , 2015, Human immunology.
[16] M. Colonna,et al. The multifaceted biology of plasmacytoid dendritic cells , 2015, Nature Reviews Immunology.
[17] M. Menon,et al. The expanding family of regulatory B cells , 2015, International immunology.
[18] D. Tyler,et al. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy , 2015, Cancer Immunology Research.
[19] A. Boonstra,et al. The role of Kupffer cells in hepatitis B and hepatitis C virus infections. , 2014, Journal of hepatology.
[20] A. Bácsi,et al. TLR ligands upregulate RIG‐I expression in human plasmacytoid dendritic cells in a type I IFN‐independent manner , 2014, Immunology and cell biology.
[21] Amit Bar-Or,et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.
[22] P. Kubes,et al. Immune surveillance by the liver , 2013, Nature Immunology.
[23] J. Werner,et al. Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer , 2013, Oncoimmunology.
[24] P. Xie,et al. M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway , 2013, Laboratory Investigation.
[25] G. Tortora,et al. Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy , 2013, Front. Pharmacol..
[26] G. Hartmann,et al. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. , 2013, Cancer research.
[27] L. Zender,et al. T-helper-1-cell cytokines drive cancer into senescence , 2013, Nature.
[28] K. Olive,et al. Genetically engineered mouse models of pancreatic cancer. , 2012, Cancer journal.
[29] R. Gibbs,et al. Genomic sequencing of key genes in mouse pancreatic cancer cells. , 2012, Current molecular medicine.
[30] R. Strong,et al. The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. , 2010, Structure.
[31] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[32] G. Prince,et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent , 2010, Mucosal Immunology.
[33] Leaf Huang,et al. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.
[34] Yusuke Sato,et al. Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment , 2009, Cancer Microenvironment.
[35] C. Berking,et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. , 2009, The Journal of clinical investigation.
[36] R. Vonderheide,et al. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. , 2009, Cancer letters.
[37] Svetlana Shulga Morskaya,et al. 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma , 2008, Nature Medicine.
[38] M. Gale,et al. Differential recognition of double-stranded RNA by RIG-I–like receptors in antiviral immunity , 2008, The Journal of experimental medicine.
[39] B. Arun,et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells , 2008, Autophagy.
[40] B. Williams,et al. The response of mammalian cells to double-stranded RNA. , 2007, Cytokine & growth factor reviews.
[41] D. Tuveson,et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.
[42] Kathryn Trinkaus,et al. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy , 2007, Molecular Cancer.
[43] D. Schuppan,et al. Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer , 2005, Gut.
[44] K. Knutson,et al. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy , 2005, Cancer Immunology, Immunotherapy.